MedTrace Logo

Circulating Myokine Levels and Bone Metabolism

NCT04206618 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 220

Last updated 2021-01-12

No results posted yet for this study

Summary

Circulating levels of several myokines will be measured in serum samples obtained from women in various categories of bone density and according to the presence of fracture or not as well as before and after treatment with teriparatide and denosumab

Conditions

  • Osteoporosis, Postmenopausal

Interventions

DRUG

Teriparatide

1 subcutaneous injection daily for 12 months

DRUG

Denosumab

1 subcutaneous injection every 6 months for 12 months

Sponsors & Collaborators

Principal Investigators

  • Athanasios Anastasilakis, phD · 424 General Military Hospital

Eligibility

Min Age
20 Years
Max Age
85 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-06-01
Primary Completion
2020-09-30
Completion
2020-11-10
FDA Drug
Yes

Countries

  • Greece

Study Locations

More Related Trials

Entities

Drugs
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04206618 on ClinicalTrials.gov